Get emailed when this bill changes status, is amended, or advances.
Disclaimer: This page provides general informational summaries only and does not constitute legal advice. AI-generated content may contain errors. Always consult a qualified attorney for guidance specific to your situation.
Read full disclaimer →
HB5022 requires congressional approval for exporting advanced AI semiconductors to China. Full implications are unclear without the complete bill text.
The No Advanced Chips for the CCP Act of 2025 mandates congressional approval for exporting advanced AI semiconductors to China. The bill is in 'Introduced' status and has been referred to the House Committee on Foreign Affairs. Note that specific definitions, exceptions, penalties, enforcement mechanisms, and 'other purposes' cannot be fully assessed without the complete bill text.
Key Provisions
Requires congressional approval for exporting advanced AI semiconductors to China.
Specific definitions, exceptions, penalties, and enforcement mechanisms are not confirmed due to unavailable full bill text.
The mention of 'other purposes' could imply additional provisions not covered in this analysis, and full implications cannot be assessed without the complete bill text.
Latest Legislative Action
Referred to the House Committee on Foreign Affairs.
Compliance Checklist
Obtain congressional approval for semiconductor exports Who: Companies exporting advanced AI semiconductors Penalty: Potential bans on exports or fines
Full Legal Analysis
HB5022, titled the No Advanced Chips for the CCP Act of 2025, has been introduced in the United States Congress. The bill seeks to require congressional approval for the export of advanced artificial intelligence semiconductors to the People's Republic of China. The official description also mentions 'other purposes,' which could imply additional provisions not covered in this analysis. The bill is currently in the 'Introduced' status and has been referred to the House Committee on Foreign Affairs. Specific definitions and exceptions, such as those for medical devices or detailed reporting requirements, are not confirmed due to the lack of available full bill text. Information on penalties or enforcement mechanisms is not available at this time. This analysis is based on the official description, and the full implications cannot be assessed without the complete bill text.
We use cookies for analytics to understand how visitors use this site. We also use essential cookies for site functionality.
See our Privacy Policy for details.